Skip to main content
RCUS $29.48 +2.15%
RCUS logo

RCUS · Arcus Biosciences, Inc.

Track RCUS — free
$29.48 +0.62 (+2.15%) At close · Aug 14
Market Cap
$3.75B
Shares
127.33M
All earnings calls

Earnings call · FY2022 Q1

Arcus Biosciences, Inc. Q1 FY2022 Earnings Call

Arcus Biosciences, Inc. Q1 FY2022 Earnings Call

Concluded May 9, 2022
May 9, 2022 0 turns
Period
FY2022 Q1
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $18.00M +90.3% YoY
Net income -$68.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Gilead Access Rights$8.32M +7.8% YoY
License and Development Services for All Gilead Programs$7.94M
Taiho Access Rights$1.75M +0% YoY
Full-screen source Call document